Enabled by deep industry verticalized teams and accelerators combined with integrated services and agentic capabilities – driving enterprise-wide AI adoption at scale EPAM Systems, Inc. (NYSE: EPAM) today announced the launch of AI/Run™.Transform Playbook- the next-generation of integrated consulting services built with AI to boost enterprise-wide AI-native transformation. The ROI-driven Playbook leverages EPAM's industry expertise […]

The much-anticipated Sammaan For All Diwali at Times Square is back, celebrating its milestone 10th Anniversary on the new date – Sunday, November 9, 2025. https://mma.prnewswire.com/media/2803280/Diwali_at_Times_Square.jpg Originally scheduled for October 12, the festival was postponed due to inclement weather. The 2025 celebration promises to be even more spectacular – bringing together communities from all backgrounds

Verismo Therapeutics, a clinical-stage CAR T company developing a novel KIR-CAR platform technology, today announced its participation and sponsorship of the International Mesothelioma Interest Group (iMig) 2025 Conference. The company will highlight STAR-101, an ongoing Phase 1 clinical trial of Verismo's lead pipeline SynKIR™-110 in patients with advanced mesothelin-expressing cancers, including mesothelioma. https://mma.prnewswire.com/media/1881639/Verismo_2022_Logo.jpg Mesothelioma is

Accelerates ETHZilla's ability to securitize real-world assets on-chain Offers exchange capabilities to expand investor access to compliant digital securities ETHZilla to take a 15% equity stake in Satschel, Inc. to further align interests ETHZilla Corporation (Nasdaq: ETHZ) (“ETHZilla” or the “Company”), a technology company bridging traditional finance and decentralized finance, today announced a strategic partnership

Wheels Up Experience Inc. (NYSE: UP) today announced that it will release its third quarter 2025 financial results on Wednesday, November 5, 2025. https://mma.prnewswire.com/media/1776408/Wheels_Up_Logo.jpg Earnings materials will be available on the Wheels Up investor relations website at investors.wheelsup.com. About Wheels Up Wheels Up is a leading provider of on-demand private aviation in the U.S. with

Reimagining and replatforming science for the era of AI TetraScience, the Scientific Data and AI Company, today launched its Scientific AI Lighthouse (SAIL) program with Takedaas founding partner. This program introduces a new model designed to transform how biopharma R&D and manufacturing are conducted in the era of AI. https://mma.prnewswire.com/media/2749538/tetrascience_logo_logo_color_Logo.jpg As a founding SAIL partner,

Mallinckrodt plc, a global specialty pharmaceutical company, announced today that it will report its third quarter 2025 financial results on Monday, November 10, 2025, before market open. The Company will host a conference call on the same day at 8:00 a.m. ET. https://mma.prnewswire.com/media/167103/mallinckrodt_plc_logo.jpg The audio webcast may be accessed through the Investor Relations section of

High Tide Inc. (“High Tide” or the “Company”) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that its Canna Cabana retail cannabis store located at 518 Centennial Pkwy North in Hamilton, Ontario, will begin selling recreational cannabis products and consumption accessories

Healthkind announced today the launch of Healthkind Nudge, an AI-powered communication service designed to transform how healthcare organizations engage with patients. With clinics struggling to manage rising patient volumes and no-show rates, Healthkind Nudge automates appointment confirmations and preparation instructions using intelligent two-way text conversations – giving patients instant access to accurate information while freeing

— VIAL-INHBE is a novel, GalNAc-conjugated INHBE (Activin E) siRNA for the treatment of obesity and other cardiometabolic indications with a projected Q6M dosing interval — VIAL-INHBE DIO mouse model data demonstrated compelling fat-selective weight-loss and lean mass preservation — Combination therapy with a low-dose GLP-1 resulted in synergistic weight loss and lean mass preservation